Dexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells' Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway.
- Resource Type
- Article
- Source
- Canadian Respiratory Journal; 7/31/2022, p1-11, 11p
- Subject
- Language
- ISSN
- 11982241